Xingming Deng

10.6k total citations
103 papers, 7.4k citations indexed

About

Xingming Deng is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Xingming Deng has authored 103 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 41 papers in Oncology and 11 papers in Cell Biology. Recurrent topics in Xingming Deng's work include Cell death mechanisms and regulation (38 papers), DNA Repair Mechanisms (17 papers) and Cancer-related Molecular Pathways (16 papers). Xingming Deng is often cited by papers focused on Cell death mechanisms and regulation (38 papers), DNA Repair Mechanisms (17 papers) and Cancer-related Molecular Pathways (16 papers). Xingming Deng collaborates with scholars based in United States, China and Japan. Xingming Deng's co-authors include W. Stratford May, Boyd K. Carr, Fengqin Gao, Peter P. Ruvolo, Takahiko Ito, Meiguo Xin, Tammy Flagg, Fadlo R. Khuri, Lijun Xu and Taofeek K. Owonikoko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Xingming Deng

103 papers receiving 7.3k citations

Peers

Countries citing papers authored by Xingming Deng

Since Specialization

Citations

This map shows the geographic impact of Xingming Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingming Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingming Deng more than expected).

Fields of papers citing papers by Xingming Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingming Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingming Deng. The network helps show where Xingming Deng may publish in the future.

Co-authorship network of co-authors of Xingming Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xingming Deng. A scholar is included among the top collaborators of Xingming Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingming Deng. Xingming Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SAMHD1 deacetylation by SIRT1 promotes DNA end resection by facilitating DNA binding at double-strand breaks 2022 ·Nature Communications ·Priya Kapoor-Vazirani, Sandip Kumar Rath, Xu Liu, Zhen Shu, (unknown), Yitong Chen, (unknown), Waaqo Daddacha, Elizabeth V. Minten, (unknown), (unknown), Duc M. Duong, Nicholas T. Seyfried, Xingming Deng, Eric A. Ortlund, Baek Kim, David S. Yu	17
2	PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Yuanchi Weng, (unknown), Xiaomei Tang, (unknown), Xingming Deng, Yu Wang, Bairong Shen	2
3	Mcl-1 Interacts with Akt to Promote Lung Cancer Progression 2019 ·Cancer Research ·Guo Chen, Dongkyoo Park, Andrew T. Magis, Madhusmita Behera, Suresh S. Ramalingam, Taofeek K. Owonikoko, Gabriel Sica, Keqiang Ye, Chao Zhang, Zhengjia Chen, Walter J. Curran, Xingming Deng	27
4	Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin 2017 ·Clinical Cancer Research ·Xu Wang, Jonathan J. Beitler, Wen‐Chin Huang, Guo Chen, Guoqing Qian, Kelly R. Magliocca, Mihir R. Patel, Amy Y. Chen, Jun Zhang, Sreenivas Nannapaneni, Sungjin Kim, Zhengjia Chen, Xingming Deng, Nabil F. Saba, Zhuo Georgia Chen, Jack L. Arbiser, Dong M. Shin	23
5	Phosphorylated Bcl-2 and Mcl-1 as prognostic markers in small cell lung cancer 2016 ·Oncotarget ·(unknown), Gabriel Sica, Sungjin Kim, Zhengjia Chen, Aaron M. Goodman, (unknown), Xingming Deng, Taofeek K. Owonikoko	6
6	Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer 2016 ·Journal of Translational Medicine ·Taofeek K. Owonikoko, Guojing Zhang, Hyun S. Kim, (unknown), Rabih Bechara, Chao Zhang, Zhengjia Chen, Nabil F. Saba, Suchita Pakkala, Rathi N. Pillai, Xingming Deng, Shi-Yong Sun, Michael R. Rossi, Gabriel Sica, Suresh S. Ramalingam, Fadlo R. Khuri	73
7	Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy 2015 ·Cancer Cell ·(unknown), Dongkyoo Park, Rui Li, Maohua Xie, Taofeek K. Owonikoko, Guojing Zhang, Gabriel Sica, Chunyong Ding, Jia Zhou, Andrew T. Magis, Zhuo G. Chen, Dong M. Shin, Suresh S. Ramalingam, Fadlo R. Khuri, Walter J. Curran, Xingming Deng	96
8	RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy 2013 ·Clinical Cancer Research ·Mohammad Aminur Rahman, A.R.M. Ruhul Amin, Dongsheng Wang, Lydia Koenig, Sreenivas Nannapaneni, Zhengjia Chen, Zhibo Wang, Gabriel Sica, Xingming Deng, Zhuo Chen, Dong M. Shin	99
9	Novel Small-Molecule Inhibitors of Bcl-XL to Treat Lung Cancer 2013 ·Cancer Research ·Dongkyoo Park, Andrew T. Magis, Rui Li, Taofeek K. Owonikoko, Gabriel Sica, Shi‐Yong Sun, Suresh S. Ramalingam, Fadlo R. Khuri, Walter J. Curran, Xingming Deng	59
10	Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer 2013 ·Molecular Cancer Therapeutics ·Shuo You, Rui Li, Dongkyoo Park, Maohua Xie, Gabriel Sica, Ya Cao, Zhi‐Qiang Xiao, Xingming Deng	147
11	Bcl2 Induces DNA Replication Stress by Inhibiting Ribonucleotide Reductase 2013 ·Cancer Research ·Maohua Xie, Yun Yen, Taofeek K. Owonikoko, Suresh S. Ramalingam, Fadlo R. Khuri, Walter J. Curran, Paul W. Doetsch, Xingming Deng	39
12	Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer 2013 ·Molecular Cancer Therapeutics ·Rui Li, Zhongliang Hu, Shi‐Yong Sun, Zhuo G. Chen, Taofeek K. Owonikoko, Gabriel Sica, Suresh S. Ramalingam, Walter J. Curran, Fadlo R. Khuri, Xingming Deng	129
13	EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells 2013 ·International Journal of Oncology ·Xiaoqian Ma, Zhijie Xu, Lifang Yang, Lanbo Xiao, Min Tang, Jingchen Lu, San Xu, Yiping Tang, (unknown), Xingming Deng, Lunquan Sun, Ya Cao	15
14	The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis 2013 ·Molecular Cancer ·Hui Ren, Junghui Koo, Baoxiang Guan, Ping Yue, Xingming Deng, Mingwei Chen, Fadlo R. Khuri, Shi‐Yong Sun	65
15	Rapamycin Induces Bad Phosphorylation in Association with Its Resistance to Human Lung Cancer Cells 2011 ·Molecular Cancer Therapeutics ·Yan Liu, Shi‐Yong Sun, Taofeek K. Owonikoko, Gabriel Sica, Walter J. Curran, Fadlo R. Khuri, Xingming Deng	40
16	Bcl2 Negatively Regulates DNA Double-Strand-Break Repair through a Nonhomologous End-Joining Pathway 2008 ·Molecular Cell ·Qinhong Wang, Fengqin Gao, W. Stratford May, Zhang Yang-de, Tammy Flagg, Xingming Deng	90
17	Mechanism of apoptosis induction by chemical inhibitors of bcl-2 in acute leukemia cells 2006 ·Cancer Research ·Marina Konopleva, Rooha Contractor, Peter P. Ruvolo, Xingming Deng, Ismael Samudio, Yuexi Shi, Teresa McQueen, Ruiyu Wang, Wendy Schober, Xiaoyang Ling, Frank C. Marini, David T. Harris, Zeev Estrov, James A. McCubrey, W. Stratford May, Michael Andreeff	2
18	Protein Phosphatase 2A Enhances the Proapoptotic Function of Bax through Dephosphorylation 2006 ·Journal of Biological Chemistry ·Meiguo Xin, Xingming Deng	116
19	Survival Function of Protein Kinase Cι as a Novel Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated Bad Kinase 2005 ·Journal of Biological Chemistry ·Zhaohui Jin, Meiguo Xin, Xingming Deng	43
20	Regulation of Bcl2 Phosphorylation and Potential Significance for Leukemic Cell Chemoresistance 2000 ·JNCI Monographs ·Xingming Deng, Steven M. Kornblau, Peter P. Ruvolo, W. Stratford May	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact